This page includes links to articles highlighting the top breast cancer research published on Cancer Therapy Advisor in 2024.

Many patients with multiple myeloma experience persistent pain and use opioids to manage that pain even after they achieve remission, a survey suggests.

(HealthDay News) — Health care spending in the United States reached $4.9 trillion ($14,570 per person) in 2023, according to data published in Health Affairs. Researchers found that US health care ...

This page includes links to articles highlighting the top hematologic cancer research published on Cancer Therapy Advisor in ...

Research presented at ASH 2024 could change the treatment of patients with newly diagnosed and relapsed or refractory MM, ...

Source: Getty Images Data presented at SABCS 2024 suggest that certain patients can safely skip sentinel lymph node biopsy, ...

The FDA has approved Tevimbra (tislelizumab) for use in combination with chemotherapy to treat unresectable or metastatic, HER2-, PD-L1+ gastric or GEJ adenocarcinoma.

Bicistronic CAR T-cell therapy can produce durable complete responses in pediatric patients with relapsed or refractory B-ALL, data suggest.

Research presented at ASH 2024 has shed new light on treatment strategies for mantle cell lymphoma and follicular lymphoma.

There is no indication that Luigi Mangione, the man charged with killing UnitedHealthcare CEO Brian Thompson, was ever a client of UnitedHealthcare, according to authorities.

(HealthDay News) — The mean body mass index (BMI) and prevalence of obesity declined in the United States in 2023, according to research published in JAMA Health Forum.

Both dose levels of modakafusp alfa “resulted in good response rates with similar safety profiles,” according to researchers.